Rhein

Rhein

SCHEMBL5076596

Cc1nc(C)c(C)nc1C.O=C(O)c1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.82
MAPT P10636 5/20 0.82
MEN1 O00255 5/20 0.82
KMT2A Q03164 5/20 0.82
TDP1 Q9NUW8 4/20 0.82
TTR P02766 4/20 0.82
HPGD P15428 4/20 0.82
CYP3A4 P08684 3/20 0.82
RECQL P46063 3/20 0.82
TSHR P16473 3/20 0.82
KDM4E B2RXH2 3/20 0.82
LMNA P02545 3/20 0.82
SMN1; SMN2 Q16637 3/20 0.82
FTO Q9C0B1 3/20 0.82
POLB P06746 2/20 0.82
ALOX15 P16050 2/20 0.82
HSD17B10 Q99714 2/20 0.82
HSP90AA1 P07900 2/20 0.82
HSP90AB1 P08238 2/20 0.82
CASP7 P55210 2/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rhein SCHEMBL25253 0.90 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ATDP1
Rhein SCHEMBL29404324 0.90 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ATDP1
Rhein SCHEMBL8012677 0.89 ALDH1A1 (0.97) ALDH1A1MAPTMEN1KMT2ATDP1
Rhein SCHEMBL23632984 0.89 ALDH1A1 (0.97) ALDH1A1MAPTMEN1KMT2ATDP1
Rhein SCHEMBL1357918 0.89 ALDH1A1 (0.97) ALDH1A1MAPTMEN1KMT2ATDP1
Rhein SCHEMBL23632879 0.89 ALDH1A1 (0.97) ALDH1A1MAPTMEN1KMT2ATDP1
Rhein SCHEMBL23633120 0.89 ALDH1A1 (0.97) ALDH1A1MAPTMEN1KMT2ATDP1
Rhein SCHEMBL23632868 0.89 ALDH1A1 (0.97) ALDH1A1MAPTMEN1KMT2ATDP1
Rhein SCHEMBL526035 0.89 ALDH1A1 (0.97) ALDH1A1MAPTMEN1KMT2ATDP1
Rhein SCHEMBL1356821 0.89 ALDH1A1 (0.97) ALDH1A1MAPTMEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1913940-B1 RHEIN CONJUGATES, PREPARATION METHOD THEREOF AND THEIR USES IN PRODUCING MEDICINES FOR TREATING DIABETIC NEPHROSIS, INTESTINAL ADHESION AND OSTEOARTHRITIS CONG XIAODONG (CN) 2018-11-21 EP disclosed
US-9181172-B2 Rhein conjugates, preparation method thereof and their uses in producing medicines for treating diabetic nephrosis, intestinal adhesion and osteoarthritis CONG XIAODONG (CN) 2015-11-10 US disclosed
US-20080207758-A1 Reaction product of rhein with bases or amino acids; antidiabetic agents; gastrointestinal disorders; antiarthritic agents CONG XIAODONG 2008-08-28 US disclosed
EP-1913940-A1 RHEIN CONJUGATES, PREPARATION METHOD THEREOF AND THEIR USES IN PRODUCING MEDICINES FOR TREATING DIABETIC NEPHROSIS, INTESTINAL ADHESION AND OSTEOARTHRITIS Jiangsu Lianchuang Pharmaceutical Technology Co. (CN) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207758-A1 Reaction product of rhein with bases or amino acids; antidiabetic agents; gastrointestinal disorders; antiarthritic agents ARGLU1, RO60, CROCC ALDH1A1 3432/4885MAPT 3631/4885MEN1 837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.